NORTH AMERICA SEQUENCING REAGENTS MARKET 2021-2028

Description

MARKET OUTLOOK

As per CRI’s report, the sequencing reagents market in North America is assessed to display a CAGR of 12.61% over the predicted years 2021-2028. The United States and Canada outline the market in this region.
The COVID-19 outbreak created several growth opportunities for the genomics segment in the biotechnology sector in the US. In this regard, the practices of genomic applications, such as SARS-CoV-2 virus surveillance, have significantly grown since the beginning of the pandemic. However, other practices like non-invasive prenatal genetic testing, DNA-based forensics, direct-to-consumer ancestry investigating, and genetic disease diagnostics are majorly conducted following the launch of the Human Genome Project. Besides, genomics has emerged as the preferred scientific research for microbiology and oncology. Thus, these developments are supporting the growth of the sequencing reagents market in the US.
On the other hand, Canada is organizing several events and conferences to offer an open platform to strengthen synthetic biology and its application. For instance, 10x Genomics invested significantly in the development and launch of new products, along with an expansion of its commercial operations. Besides, Canada SynBio, the first national conference on synthetic biology, was conducted to unite professors, students, industry leaders, and policymakers across the country to discuss success stories relating to genomics and gene synthesis. Hence, these initiatives are responsible for the robust growth of the sequencing reagents market growth.

COMPETITIVE OUTLOOK

The distinguished companies in the sequencing reagents market are LGC Biosearch Technologies, Qiagen NV, BGI Genomics, Agilent Technologies Inc, Takara Bio Inc, Perkinelmer Inc, and Trilink Biotechnologies Inc

TABLE OF CONTENTS

1. NORTH AMERICA SEQUENCING REAGENTS MARKET – SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH ON GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING
3. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS
4. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES
5. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING
6. NORTH AMERICA SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS
7. NORTH AMERICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. UNITED STATES
7.1.2. CANADA
8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: UNITED STATES SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: CANADA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)